Japan Daily Briefing

SoftBank Group's ADR (SFTBY) fell 7.06%, its sharpest single-session decline since March, as the AI-debt-worry narrative that crushed CoreWeave -15.5% in the US rippled across the Pacific. Vision Fund's portfolio of US and global growth-tech names faces a valuation headwind when US 10-year yields push above 5%. The read is portfolio-level: SoftBank's leverage model — predicated on low-cost perpetual debt — is what is being repriced, not the underlying AI demand story.

Toyota (TM) +2.03% and Honda (HMC) +1.70% kept Japan's auto complex well-bid, consistent with the broader Asia auto theme: Hyundai committed $15.5B in India capex today. Tokyo Electron and the broader semicap complex (Electronics +0.21%) essentially went sideways — unusual given the US rate shock context. Japan's auto outperformance while growth tech sells is the classic TOPIX value-day read: PBR<1 stocks with strong cashflow winning over Vision Fund leverage plays. BoJ's policy silence on USD/JPY (currently in the 145-150 range) is benign for the export thesis.

Takeda Pharmaceutical (TAK) +3.47% was Japan's top-performing liquid name on Thursday, benefiting from a defensive rotation as growth tech sold off globally. Pharma's outperformance in risk-off sessions is a well-worn playbook: TAK's ~4.5% dividend yield and JPY-hedge dynamics make it a natural safe haven when USD/JPY is volatile. Should BoJ signal tolerance for a weaker yen (above 152), the trade rotates back toward exporters (autos, electronics) and away from domestics — but that signal has not arrived yet.